SWS disclosed its semi-annual report on August 27. In the first half of 2026, the company achieved operating revenue of 464 million yuan, up 29.8 percent year on year. Net profit attributable to shareholders of the listed company was 94.37 million yuan, up 71.46 percent year on year. Basic earnings per share were 0.2968 yuan. The company plans to distribute a cash dividend of 2 yuan, tax included, for every 10 shares. During the reporting period, the company's product market share continued to rise, driving steady growth in sales revenue from blood purification equipment. Sales revenue from self-produced blood purification consumables increased significantly. As production and sales volumes rose, the fixed cost per unit of self-produced consumables declined and gross margin improved, further strengthening overall profitability.
SWS Hemodialysis Care Co. Ltd. ANet profit up 71.46% and proposed dividend